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Abstract
The developing mammary gland depends on several transcription-dependent networks to define cellular identities and dif-
ferentiation trajectories. Recent technological advancements that allow for single-cell profiling of gene expression have 
provided an initial picture into the epithelial cellular heterogeneity across the diverse stages of gland maturation. Still, a 
deeper dive into expanded molecular signatures would improve our understanding of the diversity of mammary epithelial 
and non-epithelial cellular populations across different tissue developmental stages, mouse strains and mammalian species. 
Here, we combined differential mammary gland fractionation approaches and transcriptional profiles obtained from FACS-
isolated mammary cells to improve our definitions of mammary-resident, cellular identities at the single-cell level. Our 
approach yielded a series of expression signatures that illustrate the heterogeneity of mammary epithelial cells, specifically 
those of the luminal fate, and uncovered transcriptional changes to their lineage-defined, cellular states that are induced 
during gland development. Our analysis also provided molecular signatures that identified non-epithelial mammary cells, 
including   adipocytes, fibroblasts and rare immune cells. Lastly, we extended our study to elucidate expression signatures 
of human, breast-resident cells, a strategy that allowed for the cross-species comparison of mammary epithelial identities. 
Collectively, our approach improved the existing signatures of normal mammary epithelial cells, as well as elucidated the 
diversity of non-epithelial cells in murine and human breast tissue. Our study provides a useful resource for future studies 
that use single-cell molecular profiling strategies to understand normal and malignant breast development.
Keywords Single-cell RNA sequencing · Mammary epithelial lineages · Mammary immune cells · Gene expression · breast 
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Introduction
The heterogenous cellularity of solid tissues controls the 
specialized events needed for prompt transitions through 
various stages of development and tissue function. Particu-
larly for mammary tissue, a comprehensive understanding 
of the developing gland begins with the ability to appreciate 
how its constituent parts coexist and maintain tissue homeo-
stasis and milk production. Within the mammary epithelium, 
immature, stem-like cells (Mammary Stem Cells or MaSCs) 
support repopulation of the myoepithelial and luminal cell 
lineages [1–5]. Myoepithelial cells, that are connected to the 
basement membrane, further interact with luminal cells to 
aid in the contraction of the mammary ducts in response to 
offspring suckling [6, 7]. Luminal cells comprise an array of 
distinct cellular states, which drive processes associated with 
milk production [8, 9]. Mammary fibroblasts, which reside 
in proximity to myoepithelial cells, contribute to branch-
ing expansion and epithelium survival [10, 11]. Similarly, 
immune cells play a role in branching morphogenesis of 
the mammary epithelium and tissue regression during post-
lactational involution [12, 13]. These diverse cell types sus-
tain the plasticity of the mammary gland through successive 
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stages of puberty, gestation, lactation and involution, mak-
ing it one of the most developmentally dynamic tissues in 
mammals.
Generally, transcriptional regulation represents one of the 
key mechanisms that drive mammary epithelial cell plastic-
ity. To extrapolate information from underlying transcrip-
tional networks, previous studies have employed several 
strategies to link cellular and molecular states to mammary 
epithelial identity. For example, combining flow cytomet-
ric isolation with functional cellular markers has improved 
our understanding of the dynamics of lineage commitment, 
differentiation processes and mammary tissue development 
[5, 14–17]. More recently, single-cell sequencing strategies 
have enabled the interpretation of contiguous cellular cues 
and epithelial lineage dynamics in the developing mammary 
gland [8, 15, 18–23].
In this study, we utilized differential tissue fractionation 
and single cell RNA sequencing (scRNA-seq), to expand 
molecular signatures that assign lineage identity, and to 
characterize the heterogeneity of epithelial, immune and 
stromal cells within the post-pubescent murine mammary 
gland. This strategy enabled the examination of molecular 
signatures for both mammary epithelial and non-epithelial 
cell populations, which have remained unresolved in prior 
approaches. Our analysis also extends to datasets derived 
from women’s breast tissue, which allowed for the elabo-
ration of gene signatures that resolved breast resident cell 
populations. By employing a single-cell, lineage identifica-
tion approach, we further illustrate the evolutionary con-
servation of epithelial lineages across distant mammalian 
species through the comparative integration of analyses 
from human and murine mammary tissue. Collectively, our 
study provides a comprehensive gene signature for the char-
acterization of mammary resident cell lineages, serving as a 
reference to better understand all aspects of cellular dynam-
ics and evolutionary conservation during mammary gland 
development.
Results
Defining Mammary Epithelial and Non‑epithelial 
Cell Populations
To provide a comprehensive, molecular signature that 
allows for the resolution of population heterogeneity within 
the murine mammary gland, we employed two tissue dis-
sociation protocols to selectively enrich for either epithe-
lial cells (luminal and myoepithelial cells, Protocol #1) and 
non-epithelial cells (immune and stromal cells, Protocol #2) 
from mammary glands of adult, never pregnant, female mice 
(Supplementary Fig. S1A). scRNA-seq was performed on 
each of the enriched cells, and clustering analyses resolved 
fifteen total murine mammary clusters of cells (mTM), 
which were composed of a total of 15,359 cells isolated from 
both digestion strategies (Fig. 1A, B).
To differentiate between the epithelial and non-epithelial 
cell types within the fifteen mTM clusters, we utilized the 
transcriptional levels of classic markers of lineage iden-
tity. Clusters mTM5, mTM6 and mTM7 were comprised of 
epithelial cells given the expression of epithelial markers, 
such as Epithelial cell adhesion molecule (Epcam, pan- 
epithelial marker, mTM5, mTM6 and mTM7) [24], 
Cytokeratin 18 (Krt18, luminal epithelial marker, mTM7 and 
mTM5) [25, 26] and, Cytokeratin 5 (Krt5, myoepithelial/
progenitor marker, mTM6) [26] (Fig. 1C, D). Immune cell 
lineages were classified according to the expression of Clus-
ter of differentiation 3e (Cd3e, T-lymphocytes, mTM2, 
mTM3, mTM4, mTM13, mTM15) [27], Membrane Spanning 
4-Domains A1 (Ms4a1, B-lymphocytes, mTM1, mTM9, 
mTM10) [28] and, Transmembrane immune signaling 
adaptor (Tyrobp, Myeloid, mTM8, mTM11, mTM12) [29]. 
Our analysis also indentified the presence of mixed-lineage 
stromal cells, marked by the expression of Actin alpha 2 
(Acta2), and Fatty acid-binding protein 4 (Fabp4, putative 
fibroblasts and/or adipocyte-like cells, mTM14) [30–32] 
(Fig. 1C, D).
Such cluster identity classification indicated that utili-
zation of Protocol #1 allowed for a 2.5-fold enrichment of 
murine mammary epithelial cells (mEC, luminal and myoep-
ithelial cells) over Protocol #2, which yielded an  8-fold  
enrichment in murine non-epithelial cells (mNEC, fibro-
blasts, immune cells, adipocytes) (Supplementary Fig. S1B). 
Further gene expression analysis identified a series of genes, 
previously described to define specific lineage states of 
mammary epithelial populations, to be also expressed by 
cells from non-epithelial clusters [18, 21, 33, 34] (Supple-
mentary Fig. S1C). Collectively, these analyses illustrated 
the technical relevance of tissue dissociation strategies for 
the characterization of cell-specific identities and analysis of 
cellular heterogeneity within mammary tissue.
Improving the Classification of Mammary 
Epithelial Cell Populations
To broaden the expression signatures that define epithelial line-
age identities, we utilized a re-clustering strategy of the 2,016 
cells expressing Epcam, Krt8, Krt18, Krt5 and Krt14. These 
secondary clusters comprised of epithelial cells arose from 
both digestion protocols but was predominantly composed of 
Protocol #1 cells (Supplementary Fig. S2A, B). Analysis of the 
expression of genes from distinct stages of the estrous cycle 
and cell cycle progression suggested similar cycle stages for 
epithelial cells from both protocols (Supplementary Fig. S2C, 
D). This re-clustering strategy yielded ten murine Epithelial 
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Fig. 1  Identification of specific populations of mammary epithelial 
and non-epithelial cells. (A) UMAP plot showing murine Total Mam-
mary clusters (mTM). (B) UMAP plot of cells showing the distribu-
tion of cells yielded from Protocol #1 and Protocol #2. (C) Dot plot 
and clustering (dendrogram) of mTM clusters shows the average and 
percentage of expressed genes that support classifying clusters, which 
include epithelial, lymphocytes, fibroblast and adipocyte-like cells. 
(D) Feature UMAP plots showing expression levels of epithelial 
markers (Epcam, Krt5, Krt18) and non-epithelial markers (Ms4a1, 
Cd3e and Tyrobp) across mTM clusters
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Clusters (mEC), two of which corresponded to basal compart-
ment cells (Krt5 + , mEC1 and mEC8) and eight corresponding 
to luminal cells (Krt18 + , mEC2-mEC7, mEC9 and mEC10) 
(Fig. 2A-B).
To define the distinct population of cells within the basal 
and luminal mammary compartments, we utilized previously 
published bulk RNA-seq datasets generated from FACS-
isolated mammary epithelial cells (MECs) [14–17, 21, 33]. 
Using this strategy, we defined differentially expressed genes 
(DEGs) in MaSCs, myoepithelial progenitor cells, myoepi-
thelial differentiated cells, luminal progenitor cells, luminal 
ductal cells, and luminal alveolar cells (Supplementary File 
S1). The analysis was then supplemented with DEGs defined 
for each of the scRNA-seq epithelial clusters, which together 
provided a comprehensive expression signature for the char-
acterization of epithelial lineage identities (Supplementary 
Fig. S3A and Supplementary File S2).
In line with previous studies, myoepithelial cells were 
defined by the expression of basal compartment-biased 
genes Krt5, Cytokeratin 14 (Krt14), Cytokeratin 17 (Krt17), 
Acta2, Secreted Protein Acidic and Cysteine Rich (Sparc), 
Myosin light chain kinase (Mylk), Podoplanin (Pdpn) and 
C-X-C Motif Chemokine Ligand (Cxcl14) [15, 22, 26, 
34–36]. Myoepithelial progenitor/stem cells were marked 
by the expression of genes previously shown to contribute 
to tissue reconstruction in fat pad transplantation assays and 
overall mammary developmental processes, such as Tumor 
protein p63 (Tp63) [37], Bromodomain PHD Finger Tran-
scription Factor (Bptf) [17], and classical markers of mam-
mary stem-like state, such as Leucine Rich Repeat Contain-
ing G Protein-Coupled Receptor 5 (Lgr5) [38], Neuregulin 
1 (Nrg1) [39] and Inhibitor of DNA Binding 4, HLH Protein 
(Id4) [40] (Fig. 2B and Supplementary Fig. S3A). Interest-
ingly, we did not detect abundant levels of a few known 
markers of the MaSC-like state such as Protein C Receptor 
(Procr) [41], BAF chromatin remodeling complex subu-
nit (Bcl11a) [42], and Zinc Finger E-Box Binding Home-
obox (Zeb2) [41], across all epithelial cell clusters. The 
low expression of these genes could represent differences 
in mammary tissue processing, mouse strain, mouse age, 
and mouse estrous cycle stage between our dataset and previ- 
ously published ones.
Cells from cluster mEC8, which demonstrated low lev-
els of expression of the stem-like signature, were charac-
terized as differentiated myoepithelial cells. A third clus-
ter of cells, mEC9, originally defined as belonging to a 
Krt8 + Krt18 + luminal fate, expressed elevated levels of 
Krt5, and may represent a population of putative bipotential 
progenitors predicted to express markers from both lineages 
[15, 43] (Fig. 2B and Supplementary Fig. S3A). Further-
more, cells from the mEC9 cluster showed expression of a 
set of genes identified in MaSC-like cells such as Campath-1 
antigen (CD52) [44], Ebf Transcription Factor 1 (Ebf1) [45], 
B-cell antigen receptor complex-associated protein alpha 
chain (CD79a) [14], HLA class II histocompatibility antigen 
gamma chain (CD74) [14], H-2 class II histocompatibility 
antigen, I-E beta chain (H2-eb1), H-2 class II histocompat-
ibility antigen, A beta chain (H2-ab1), and H-2 class II histo-
compatibility antigen, A-B alpha chain (H2-Aa) [21]. These 
results suggest the presence of a small population of cells 
with a bipotential, luminal/basal molecular signature within 
the mammary gland (Fig. 2B and Supplementary Fig. S3A).
The analysis of cells predicted to belong to the luminal cell 
fate resolved an array of progenitor and differentiated cells, 
according to the expression of Cyclin Dependent Kinase 
19 (Cdk19) [14], Cbp/P300 Interacting Transactivator 
with Glu/Asp Rich Carboxy-Terminal Domain 1 (Cited1) 
[8], and Cysteine Dioxygenase Type 1 (Cdo1) [46] (Fig. 2B 
and Supplementary Fig.  S3A). Within these clusters, 
mEC3, mEC6, and mEC7 aligned with the functional 
classification of ductal-like cells, given the expression of 
the functional marker, Prominin-1 (Prom1/CD133) [47], 
and the concomitant expression of hormone responsive 
genes, such as Estrogen receptor 1 (Esr1), Progesterone 
Receptor (Pgr), and Prolactin Receptor (Prlr) [8] (Fig. 2B 
and Supplementary Fig. S3A). Further analysis of ductal-like 
cells from cluster mEC3 revealed distinct cluster markers, 
such as the expression of the gene FXYD Domain Containing 
Ion Transport Regulator 2 (Fxyd2), which participates in 
mammary expansion in response to pregnancy hormones 
[48], as well as other genes with unknown functions in 
mammary epithelial cells, including Protein Phosphatase 
Methylesterase 1 (Ppme1), the Glycolipid transfer protein 
(Gltp), Glutathione S-transferase Mu 2 (Gstm2), and the 
Inositol 1,4,5-triphosphate receptor interacting protein-like 
1 (Itpripl1). We also found that the luminal ductal-like cells 
from cluster mEC6 abundantly expressed levels of additional 
genes not previously linked to mammary tissue such as 
Tetraspanin 9 (Tspan9) and Pirin (Pir).
In addition to Prom 1+ epithelial cells, our analysis iden-
tified populations of luminal alveolar-like cells (mEC2, 
mEC4, mEC5 and mEC10), that express casein-like genes, 
a cellular state that precedes the pregnancy-induced secre-
tory alveolar fates [8, 21]. Interestingly, all clusters classi-
fied as alveolar-like cells expressed abundant levels of genes 
Fig. 2  RNA-seq profiles of FACS-isolated cells improve the identifi-
cation of mammary epithelial cell populations. (A) UMAP plot dem- 
onstrating distinct mECs from a re-cluster of cells with high mRNA 
expression levels for Epcam, Krt8, Krt18, Krt5 and Krt14. (B) Dot 
plot and clustering (dendrogram) of mEC clusters shows the aver-
age and percentage of expressed genes that support specific lineage 
cell type identification. (C) UMAP projection showing a monocle-
informed transcriptional trajectory arrangement of mEC clusters. The 
arrows serve to suggest that cells tending toward a bipotential progen- 
itor fate (mEC9) give rise to myoepithelial progenitors (mEC1) and 
predicted luminal common progenitors (mEC7). (D) Feature UMAP 
plots showing expression levels of specific genes in mEC clusters
◂
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previously proposed to define a progenitor-like state, such 
as E74 Like ETS Transcription Factor 5 (Elf5), Monocyte 
differentiation antigen 14 (Cd14), KIT Proto-Oncogene, 
Receptor Tyrosine Kinase (Kit) and Enhancer Of Zeste 2 
Polycomb Repressive Complex 2 Subunit (Ezh2), [8, 18, 21, 
49, 50]. These results suggest an accumulation of partially 
differentiated luminal secretory cells in mammary tissue 
from a never pregnant, post-pubescent female mouse. We 
found that mEC4 cells expressed higher levels of Lactalbu-
min Alpha (Lalba) and S100 Calcium Binding Protein A8 
(S100a8) mRNAs [8, 51], while those from mEC5 expressed 
high levels of Aldehyde Dehydrogenase 1 Family Member 
A3 (Aldh1a3) and Transferrin (Trf) mRNAs, all previously 
associated with luminal progenitor cells [27] (Fig. 2B and 
Supplementary Fig. S3A). Cells from mEC2 were marked 
by the expression of R-Spondin 1 (Rspo1) and Fc Fragment 
of IgG Binding Protein (Fcgbp) [52, 53], while cells from 
mEC10 expressed Stathmin 1 (Stmn1) and C-X-C Motif 
Chemokine Receptor 4 (Cxcr4) [54, 55], together suggest-
ing the presence of multiple, alveolar-like progenitor states. 
Notably, cells from cluster mEC10 also expressed a set of 
genes associated with cellular growth and cell cycle progres-
sion, suggesting they exist in a state of cellular proliferation 
(Fig. 2B and Supplementary Fig. S2B).
Our MEC population analysis also identified a unique 
population of cells, cluster mEC7, marked by the expres-
sion of luminal progenitor-associated genes, such as Elf5, 
Cd14, Kit and Ezh2, as well as expression of both ductal-like 
hormone sensing markers (Prom1, Esr1, Pgr) and alveolar-
like secretory markers Casein Beta (Csn2), Casein kappa 
(Csn3), Carbonic anhydrase 2 (Car2), and Bifunctional hep-
aran sulfate N-deacetylase/N-sulfotransferase 1 (Ndst1) [56]. 
Further, cells in mEC7 selectively expressed the gene Tet 
Methylcytosine Dioxygenase 2 (Tet2), a DNA demethylase 
that plays a fundamental role in controlling the differentia-
tion potential of luminal progenitor cells [57] (Fig. 2B and 
Supplementary Fig. S3A). Therefore, we propose the cells 
in mEC7 represent a common, luminal progenitor state that 
may give rise to both hormone sensing and secretory luminal 
cell subtypes, as has been previously suggested [8].
Given the array of putative progenitor cells defined by 
the expansion of lineage-associated expression signatures, 
we next asked whether we could predict cellular transitions 
using the transcriptomic profile of each cell cluster. General 
transcriptional trajectory analysis confirmed our original 
hypothesis, that cells from cluster mEC9 likely represent 
a bipotential luminal/basal progenitor, which may precede 
the myoepithelial progenitor (mEC1) and predicted luminal 
common progenitor cells (mEC7) in the MEC lineage tree. 
The defined transcriptional trajectories also suggested that 
cells from mEC7 further split into two luminal branches 
which, in turn, gave rise to ductal-like and alveolar-like cells 
(Fig. 2C,2D and Supplementary Fig. S3B).
Pathway analysis of predicted bipotent progenitor (mEC9) 
indicated an enrichment for genes that are associated with path-
ways that control mammary stem cell maintenance, such as 
Notch signaling and IL5-signaling [58, 59] (Supplementary 
Fig. S3C, pink and Supplementary File 3). Interestingly, both 
pathways have also been described to influence mammary 
lineage commitment, with Notch biasing commitment towards 
the myoepithelial fate, and IL-5 signaling driving luminal 
specification [58, 59]. Moreover, we found that both common 
luminal progenitors (mEC7) and luminal hormone-negative 
progenitors (mEC2), were enriched for genes associated 
with Wnt signaling, which has been previously implicated 
to coordinate proliferation and differentiation of mammary 
progenitor cells [60, 61] (Supplementary Fig.S3C, blue and 
ochre, Supplementary File 3). More specifically, common 
luminal progenitors (mEC7) were defined by genes associated 
with ErbB and Insulin signaling pathways, which have been 
linked with the maintenance and expansion of the luminal 
epithelial compartment [62, 63] (Supplementary Fig. S3C, 
blue, Supplementary File 3). Altogether, analyses of genes 
preferentially expressed in clusters mEC2, mEC7 and mEC9, 
identified by our scRNA-seq analysis, support their existence 
in a more undifferentiated state. Additionally, flow cytometric 
analysis validated several of these markers confirming our 
predictions of cellular state, lending further support to our 
approach in expanding molecular signatures that assign lineage 
identities (Supplementary Fig. S4). Collectively, these analyses 
revealed a complex balance of immature and differentiated 
mammary resident epithelial cells and their putative relevance 
in maintaining homeostasis in post-pubescent, mammary tissue.
An Extended Molecular Signature 
Reveals Cellular Dynamics During 
Pregnancy‑induced Mammary Gland 
Development
We next asked whether our extended molecular signatures 
could expand our understanding of cellular dynamics during 
mammary developmental processes. In doing so, we investi-
gated a previously published dataset of scRNA-seq profiles 
derived from Epcam + mammary epithelial cells harvested 
from mice during mid gestation (day 14.5), early lactation 
(day 6) and late involution (11 days post-weaning) [8]. Given 
that these datasets were generated utilizing mammary cells 
from C57BL/6 female mice, we first investigated whether 
our ability to predict mammary lineages could be impacted 
by strain specific changes to gene expression [64–68]. We 
found that genes previously predicted to be differentially 
expressed between C57BL/6 and Balb/c show relative simi-
lar mRNA abundance in MECs from either dataset, which 
suggested that strain-specific variation in gene expression 
were not majorly represented in mammary tissue. We also 
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identified a few genes that are more abundant in C57BL/6 
nulliparous MECs, and those more abundant in Balb/c nul-
liparous MECs, and therefore consistent with the idea of 
strain-specific changes to a subset of gene expression (Sup-
plementary Fig. S5A). Most importantly, genes defined 
to characterize epithelial lineage and identity showed no 
difference in abundance across MECs from both mouse 
strains, thus suggesting that a molecular definition of the 
epithelial cell compartment is unlikely to be influenced by 
strain-specific alterations to gene expression (Supplementary 
Fig. S5B).
We next resolved a series of cellular clusters for each of 
the previously published mammary developmental stages 
datasets (Supplementary Fig. S6A, B, C and D). Each cell 
cluster was then analyzed according to the gene signatures 
defined in our scRNA-seq data from the nulliparous mam-
mary cells (Fig. 2). Overall, this analysis validated the pres-
ence of cell types identified with our expanded gene signa-
ture in datasets derived from nulliparous mammary glands 
(mN clusters, Fig. 3A), and mammary tissue at other devel-
opmental stages (Fig. 3B, C, and D).
We found that all eleven clusters identified during gesta-
tion (mG) were characterized by the expression of genes 
that define myoepithelial-like cells, such as Krt5, Krt14, 
Krt17, Acta2, amongst others, suggesting a mixed  luminal-
basal molecular identity (Fig. 3B). This was further sup-
ported by the analysis of luminal alveolar-like genes, such as 
Csn2, and Csn3 across all clusters. From the eleven clusters, 
mG1, mG2, mG3, mG4 and mG5 expressed higher levels of 
myoepithelial-biased markers, suggesting a more defined, 
myoepithelial state compared to other clusters. Conversely, 
cells from cluster mG8 had a molecular signature of the 
luminal, alveolar, progenitor state, given the high levels of 
Krt8, Krt18, Kit, Cd14 and Elf5 mRNAs. All clusters, apart 
from cluster mG8, expressed much lower levels of Epcam, 
Krt8 and Krt18 mRNAs, suggesting that signals during 
gestation may alter the expression of canonical markers of 
mammary epithelial lineage identification (Fig. 3B).
Our approach also investigated lineage-associated, 
molecular signatures in MECs isolated from mice during 
lactation (Fig. 3C). All epithelial clusters identified in lac-
tating glands (mL) expressed high levels of milk-associated 
proteins, Casein Alpha S1 (Csn1s1), Csn2 and Csn3, with 
clusters mL1, mL3, mL4, mL5 and mL6 expressing mark-
ers of progenitor, alveolar- fate such as Kit, Cd14 and Elf5. 
These clusters also expressed moderated levels of Prolac-
tin receptor (Prlr), thus supporting a milk-sensing, cellular 
state. Interestingly, cluster mL6 was marked by the expres-
sion of myoepithelial-like and luminal-like genes, suggest-
ing the presence of an epithelial bipotential cellular state 
during lactation. Cluster mL10 uniquely expressed luminal 
ductal-like genes and higher levels of genes encoding the 
hormone receptors, Esr1 and Pgr, in contrast to clusters mL2 
and mL9, which presented a myoepithelial-biased gene sig-
nature (Fig. 3C).
Clusters identified during the late stages of involution (mI) 
display a more lineage-defined state with clearer distinction 
between myoepithelial-like cells (clusters mI2 and mI8), 
and luminal-like cells (mI1, mI3, mI4, mI5, mI6, mI7, mI9, 
mI10 and mI11). Among the clusters with luminal-biased 
signatures, we observed a greater representation of luminal, 
ductal-like cell populations (clusters mI1, mI4, mI5, mI6, mI7 
and mI8), with some of them carrying both, alveolar-like and 
ductal-like signatures (mI5 and mI8). In fact, identification 
of a single cluster of cells with definitive expression of 
alveolar-like, casein genes (mI3) support the transition 
from a predominantly secretory state during lactation into 
a non-secretory, homeostatic state. Moreover, three clusters 
(mI9, mI10 and mI11) comprised of myoepithelial-like and 
luminal-like genes support the activation of a variety of stem-
like cells during involution for tissue reconstruction after 
pregnancy (Fig. 3D).
We next decided to utilize broader prediction models to 
investigate, without bias, whether global expression patterns 
from post-pubescent mammary epithelial cells (mEC, Fig. 2) 
could infer the cellular state of epithelial cells during ges-
tation, lactation and involution. Importantly, utilizing this 
approach would support the effectiveness of our extended 
molecular signatures in defining lineage identities across 
stages of adult mammary development. In concordance with 
our previous findings, MECs isolated from C57BL/6 nul-
liparous female (indicated as mN clusters) mice fit within 
the population distribution presented in Fig. 2, except for 
a population characterized as mature myoepithelial cells 
(mEC8) which was not present in any of the datasets gen-
erated from C57BL/6 animals (Fig. 3E, F, G and H). This 
difference could be explained by either the marker-specific 
isolation used for the C57BL/6 MECs (Epcam), or the rela-
tively small abundance of cells within the mEC8 cluster dur-
ing pregnancy-induced development.
Furthermore, we confirmed that cells isolated during 
gestation displayed a myoepithelial-biased molecular iden-
tity, given that many of the gestation cell clusters (mG1, 
mG2, mG3, mG4, mG5, mG6, mG8, mG9, and mG10), 
show gene expression patterns that resemble those defined 
in myoepithelial progenitor/stem-like cells (Fig. 3F). Anal-
yses of lactation-derived cellular clusters also confirmed 
our gene signature analyses, showing that global patterns 
of gene expression associated with several clusters (mL1, 
mL4, mL5, mL6, mL9) of luminal, alveolar-like cell fates in 
the pre-pubescent mammary glands (Fig. 3G). As such, pre-
dictions of global transcription suggested the prevalence of 
cells with a ductal-biased state during involution (Fig. 3H), 
thus supporting a complex cellular state during gestation, 
lactation and involution. Our analyses also demonstrated that 
populations of MECs classified as bipotent (mEC9), were 
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present across all developmental stages analyzed, whereas 
clusters with a more luminal, immature signatures (mEC2 
and mEC7) were more abundantly detected in nulliparous 
tissue, and during lactation and involution.
Pathway analyses illustrated differentially enriched 
networks within each of these clusters across pregnancy-
induced mammary development (Supplementary File S4). 
Overall, C57BL/6 nulliparous predicted bipotent (mN9) 
and progenitors (mN6 and mN5), were enriched for similar 
pathways to those of Balb/c MECs, thus supporting that 
mechanisms that control mammary cellular states are 
maintained across distinct murine strains (Supplementary 
Fig. S3C and Supplementary Fig. S7). Throughout the 
pregnancy-induced development, predicted mammary 
bipotent progenitors (gestation cluster mG6, lactation 
clusters mL7 and late involution cluster mI10) were 
enriched for immune communication pathways, mechanisms 
that could represent an adaptive signal for protection of 
stem-like cells during development, in response to the 
immune suppression that accompanies pregnancy-induced 
development. During gestation and lactation, bipotent 
progenitors were marked by pathways associated with 
calcium regulation, cellular relaxation and contraction 
(mG6 and mL7), and IL-3 signaling (mL7), all of which are 
mechanisms regulated by increased levels of Prolactin and 
known to play an important role during pregnancy-induced 
mammary development [69]. At the end of involution, the 
enrichment of genes associated with apoptotic signaling, 
insulin response and adipogenesis suggest the presence of 
mechanisms,  that are associated with hallmarks of post-
pregnancy mammary involution [70, 71] (Supplementary 
Fig. S7).
Pathway analysis for the putative luminal hormone- 
negative MECs (gestation cluster mG8, lactation cluster 
mL3, and late involution cluster mI3) and common luminal 
progenitor MECs (lactation cluster mL10 and late involution 
cluster mI5) showed enrichment of a distinct set of gene 
networks at each of the pregnancy-induced, mammary 
gland developmental stages. During gestation, luminal 
hormone-negative MECs (mG8) were enriched for pathways 
associated with lipid metabolism, suggesting their initial 
steps towards milk production (Supplementary Fig. S7). 
Curiously, our cellular prediction analysis failed to identify 
cells with a common luminal progenitor signature during 
gestation (Fig. 3F). The lack of cells carrying this signature 
during gestation could either be indicative of the rapid rate 
of differentiation of luminal cells in response to pregnancy 
hormones or may represent the pan-cellular alteration of 
gene expression signatures as observed in other cell types 
during the same developmental stage (Fig. 3B).
Moreover, during lactation, both luminal hormone- 
negative MECs and common luminal progenitor MECs 
 were marked by the enrichment of pathways associated 
with prostaglandin synthesis and regulation, which have 
been associated with lactogenic potential of MECs and 
milk maturation [72] (Supplementary Fig. S7). Both cell 
states were also enriched for genes associated with TNFα - 
NF-κβ signaling pathway, immune communication and 
adipogenesis, suggesting their role in mammary gland 
clearance and tissue remodeling post-lactation [70, 71] 
(Supplementary Fig.  S7). Collectively, our ability to 
predict immature, cellular states during mammary gland 
development, via the expansion of molecular signatures 
of nulliparous MECs, have enabled the prediction of their 
specific functional roles in response to signals present during 
gestation, lactation and involution.
In addition to the specific, molecular programs expressed by 
MECs during the pregnancy cycle, those residing in the post-
involuted mammary gland bear unique and stable molecular 
signatures [73–75]. Therefore, it is possible that these molecu-
lar changes could represent a combination of altered mammary 
cellular heterogeneity and differential transcriptional output 
of epithelial cells. With the intent to address this question, we 
next investigated whether the expression of genes previously 
described as a parity-induced signature [74], were exclusive 
to mammary epithelial cells, or shared across other mammary 
resident cell types (Fig. 1). We found that the majority of the 
parity-induced genes were expressed in our dataset, with the 
exception of the genes Secreted frizzled-related sequence protein 
4 (Sfrp4), Trypsin-like serine protease (Sprx), Mast cell protease 
2 (Mcpt2), Cop9 signalosome complex subunit 2 (Cops2), Cop9 
signalosome complex subunit 7 (Csn7), Carboxylesterase (Ces) 
and Carbonic anhydrase 3 (Ca3). Further analysis indicated that 
approximately 60% of these parity-induced signature genes were 
expressed similarly in mammary epithelial and non-epithelial 
cells, with several genes being more abundantly expressed in 
non-epithelial cells (Supplementary Fig. S8A, B). Our results 
support the reliable use of this parity-associated gene signature 
to define the pregnancy state of pre-isolated MECs but raise 
the outstanding question of whether non-epithelial cell lineages 
and heterogeneity contribute significantly to the post-pregnancy 
state of mammary tissue. Taken together, our analyses support 
an extended molecular signature of mammary epithelial line-
ages to improve the identification of cellular dynamics, even in 
Fig. 3  Extended molecular signatures reveal cellular dynamics dur-
ing pregnancy- induced mammary gland development. (A-D) Dot 
plot and dendrogram branching showing average and percentage expres-
sion of epithelial genes utilized to characterize specific epithelial cell-
type populations from mammary tissue harvested from (A) nulliparous 
female mice (mN) (B) female mice at mid-gestation (mG) (C) female 
mice during lactation (mL) and (D) female mice at late states of involu-
tion (mI). (E–H) UMAP displaying predicted cluster classifications of 
cells harvest from (E) nulliparous female mice (mN), (F) female mice 
at mid-gestation (mG), (G) female mice during lactation (mL) and 
(H) female mice at late states of involution (mI), in relation to clusters 
defined in mammary glands from nulliparous, post-pubescent female 
mice (mEC)
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conditions where the response to pregnancy signals induces 
molecular and cellular alteration to the mammary gland.
Outlining the Diversity of Non‑epithelial 
Mammary Resident Cell Types
Given that immune and stromal cells play a central role dur-
ing mammary gland development and tissue homeostasis 
[5], we next focused on defining the diversity of non-epithelial 
cells in post-pubescent never pregnant mammary tissue. 
We re-clustered non-epithelial cells (12,646 cells, with low 
mRNA levels for Epcam, Krt18, Krt8, Krt5 and Krt14 genes, 
Fig. 1C), an approach that yielded thirteen unique clusters 
of murine non-epithelial cells (mNEC, Fig. 4A). As we 
expected, we obtained most of the non-epithelial cells from 
tissue dissociation Protocol #2. (Supplementary Fig. S9A, 
B). Analyses of classic markers that define T-lymphocytes 
(Cd3), B-lymphocytes (Ms4a1), Myeloid cells (Tyrobp), 
Fibroblasts (Acta2), and Adipocytes (Fabp4) demonstrated 
the diversity of lineage identities of non-epithelial cells 
residing in mammary tissue (Fig. 4B).
With the goal of building molecular signatures to better 
define non-epithelial cellular identities, we investigated the 
Fig. 4  Outlining the diversity of mammary resident non-epithe-
lial cell types. (A) UMAP plot demonstrating distinct murine Non-
Epithelial cell clusters (mNEC) from a re-cluster of non-epithelial 
cells expressing low levels of Epcam, Krt18, Krt8, Krt5 and Krt14 
mRNAs. (B) Feature UMAP plots show expression levels of Cd3e, 
Ms4a1, Tyrobp, Acta2, Fabp4 and Npc2 mRNAs in mNEC clusters. 
(C) Dot plot and dendrogram branching showing average and per-
centage of expressed genes used to distinguish and classify diverse 
immune cell populations
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top DEGs across all non-epithelial cell clusters (Supplemen-
tary File S5). Utilizing classical markers B-lymphocyte anti-
gen Cluster of Differentiation 19 (Cd19) and Ms4a1 [76, 77], 
our analyses identified two clusters with B-lymphoid line-
age identity (mNEC1 and mNEC6). They both showed the 
expression of immunoglobulin-like genes Immunoglobulin 
Kappa Constant (Igkc), Immunoglobulin Heavy Constant 
Mu (Ighm), Immunoglobulin Heavy Constant Delta (Ighd) 
and additional B-cell markers, such as Cd79a [78], Cluster 
of Differentiation 83 (Cd83) [79], B Cell Scaffold Protein 
with Ankyrin Repeats 1 (Bank1) [80], and Paired Box 5 
(Pax5) [81] (Fig. 4C, and Supplementary Fig. S9D). Inter-
estingly, B-cell populations clustered closely with Natural 
Killer (NK) cells (mNEC12), cells known for playing an 
important role during mammary gland involution and breast 
tumorigenesis [82, 83], and that are defined by genes like 
Killer Cell Lectin Like Receptor K1 (Klrk1) [84], Killer 
Cell Lectin Like Receptor D1 (Klrd1) [85], and Sialic acid 
binding Ig-like lectin H (Siglech) [86] (Fig. 4C, and Sup-
plementary Fig. S9D).
Our analysis also identified a variety of T-lymphocytes, 
characterized by the expression of Cd3e mRNA. Among 
these, we identified Cluster of differentiation 4 (Cd4 + , 
mNEC2) and Cluster of differentiation 8 (Cd8 + mNEC3) 
expressing cells, which expressed high levels of T cell 
master regulator Lymphoid Enhancer Binding Factor 1 
(Lef1) [87, 88] (Fig. 4C, Supplementary Fig. S9C, D). In 
addition, we identified clusters of Cd4 + regulatory T-like 
cells (Treg, mNEC4 and mNEC10), which were marked 
by the expression of Treg lineage factor Forkhead box 
P3 (Foxp3) [89] and other Treg associated genes such as 
Cytotoxic T-Lymphocyte Associated Protein 4 (Ctla4) [90] 
and SH2 Domain Containing 1A (Sh2d1a) [91] (Fig. 4C, 
Supplementary Fig. S9D). Interestingly, mNEC10 Tregs were 
exclusively marked by the expression of cell cycle control 
genes, such as DNA Topoisomerase II Alpha (Top2a), Marker 
of Proliferation Ki-67 (Mki67) and Ubiquitin Conjugating 
Enzyme E2 C (Ube2c), suggesting a proliferative cellular 
state (Fig. 4C, Supplementary Fig. S9D). Moreover, we 
identified two clusters of  Cd4–Cd8– NKT-like cells (mNEC5 
and mNEC8), that expressed Cd3 mRNA and NK-associated 
genes such as Natural Killer Cell Granule Protein 7 
(Nkg7) [92], Klrk1[84], and CUGBP Elav-Like Family 
Member 2 (Celf2) [93, 94], a population of cells not well 
explored in normal mammary tissue, but that has also been 
implicated during mammary tumorigenesis [95] (Fig. 4C, 
Supplementary Fig. S9D).
Outside of the lymphocytic-biased lineage, we identified 
myeloid-biased clusters, including a population of dendritic 
cells (mNEC7), marked by the expression of dendritic master 
regulator Basic Leucine Zipper ATF-Like Transcription Fac-
tor 3 (Batf3) [96], and macrophage-like cells characterized 
by the expression of classical markers such as Cd14 [97], 
Lysozyme C-2 (Lyz2) [98] and Hexosaminidase Subunit 
Beta (Hexb) [99] (Fig. 4C, Supplementary Fig. S9D). Addi-
tional myeloid populations (neutrophils, monocytes) were 
not detected in our datasets, perhaps due to their potential 
low abundance in post-pubescent murine mammary tissue. 
Fibroblasts (mNEC11) and Adipocyte-like cells (mNEC13) 
were also detected in our datasets, based on molecular sig-
natures including Platelet Derived Growth Factor Subunit 
A (Pdgfa) and Adiponectin (Adipoq) respectively (Fig. 4C, 
Supplementary Fig. S9D). Collectively, our studies illustrate 
the effectiveness of short-term mammary digestion for the 
selective enrichment of mammary stromal and immune cells, 
including adipocytes and under-studied immune cell types. 
Our study also provided gene signatures and re-clustering 
strategies that will enable the efficient characterization of the 
diversity of such cell types in future scRNA-seq analyses of 
the developing mammary gland.
Expanded Molecular Signature of Epithelial 
and Non‑epithelial Human Breast Tissue
We next performed scRNA-seq analysis of total, non-
cancerous, nulliparous, human breast tissue, with the goal 
to further expand a molecular signature that predicts the 
lineage identity of breast resident cells (Supplementary 
Fig. S10A). Analysis of five human breast samples yielded 
eleven clusters of total breast cells (hTM), which represented 
clusters of breast epithelial cells (EPCAM +), myeloid cells 
(SERPINE1 +), T- lymphocytes (CD3E +), B-lymphocytes 
(MS4A1 +), endothelial-like cells Claudin 5 (CLDN5) and 
fibroblast-like cells (MYLK +) (Fig. 5A-B, Supplementary 
Fig. S10B). In addition, cell cycle analysis of the hTM clus-
ters suggested a similar cycle progression across all clus-
ters, supporting that the cell clustering was likely based on 
overall gene expression rather than differential expression of 
genes associated with cell cycle (Supplementary Fig. S10C).
The employment of online tools, commonly utilized to 
assign cell identities based on the gene expression of each 
cluster, yielded different cellular predictions to all clusters 
with the exception of cluster hTM11, which was predicted 
to have a B-cell lineage identity across all platforms (Sup-
plementary File S6 and Supplementary Fig. S10D). Fur-
ther analysis utilizing classic lineage markers confirmed the 
B-cell identity of hTM11, in addition to predicting identi-
ties of epithelial clusters hTM4, hTM6, hTM8 and hTM10 
(EPCAM + , KRT8 + and KRT5 +) and non-epithelial clus-
ters, based on the expression of immune markers (CD3E, 
Granzyme A (GZMA), Serpin Family E Member 1 (SER-
PINE1), A Receptor Tyrosine Kinase (AXL) and HEXB, 
endothelial markers CLDN5 [13, 27, 77, 99–104], fibroblasts 
marker Myocilin (MYOC) [105], and adipocytes markers 
Gap Junction Protein Alpha 4 (GJA4), and Procollagen 
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C-Endopeptidase Enhancer (PCOLCE) [106, 107]. We also 
noted that some lineage specific markers of non-epithelial 
cells were expressed by epithelial lineages, such as HEXB 
and AXL (Supplementary Fig. S10E). Taking together, our 
results illustrate the overall complexity of lineage composi-
tion of human breast tissue.
We next focused on defining the identity of the epithe-
lial lineages in the human breast. Using a similar approach 
employed for the characterization of murine epithelial cells, 
we identified clusters hTM4, hTM6, hTM8, and hTM10 that 
expressed high levels of epithelial markers (EPCAM, KRT8, 
and KRT18, KRT5, and KRT14) and performed re-clustering 
analysis of these cell populations. We also detected cells with 
relatively low expression of marker KRT18 (cluster hTM9). 
Given the lack of additional markers (EPCAM, KRT8, 
KRT5), these were not included to the epithelial focused 
re-clustering (Supplementary Fig. S10E).
With such approach, we defined six epithelial clusters 
(hEC), which we further characterized to define breast epi-
thelial lineage identities (Supplementary Fig. S11A, B). 
The combination of markers that defined mouse mammary 
lineages (Fig. 2), and top DEGs for each cluster, permitted 
the expansion of gene signatures that defined each of the 
epithelial clusters (Fig. 5C, Supplementary File S7, and Sup-
plementary Fig. S11C). We defined clusters of luminal-fates 
(hEC1, hEC2, and hEC4), which were classified as lumi-
nal differentiated prolactin receptor high (PRLRh, hEC1), 
luminal differentiated estrogen receptor high (ESR1h, hEC2) 
and luminal progenitor prolactin receptor high (PRLRh, 
hEC4) cells, according to their expression of EPCAM, 
KRT8, KRT18, KRT19, Claudin 4 (CLDN4), ESR1, PRLR 
mRNAs (Fig. 5C and Supplementary Fig. S11C). Our analy-
sis identified cells from the myoepithelial lineage (hEC5 and 
hEC6), which included myoepithelial progenitors (hEC5) 
and differentiated myoepithelial cells (hEC6), given the 
expression of KRT5, KRT14, Laminin Subunit Alpha 3 
(LAMA3), ACTA2, TP63, and Oxytocin Receptor gene 
(OXTR). We also found that cluster hEC3, expressed both 
classical luminal cell markers (KRT8, KRT15) and myoepi-
thelial cell markers (KRT5, KRT14, KRT16), in addition to 
progenitor markers CD14 and KIT, suggesting a putative 
immature, bipotent, cellular state (Fig. 5C and Supplemen-
tary Fig. S11C). Transcription trajectory predictions further 
suggested that cluster hEC3 may occupy an intermediary 
position during human mammary epithelial differentiation 
across luminal and myoepithelial identities (Fig. 5D and 
Supplementary Fig. S11D).
Further molecular analysis revealed specialized mecha-
nisms associated with each of the epithelial identities (Sup-
plementary Fig. S11E, F, G, H, I and J, and Supplementary 
File 8). Luminal identities were supported by the enrichment 
of pathways associated with Prolactin signaling in luminal 
differentiated PRLR cells (hEC1), while luminal differen-
tiated ESR1 cells (hEC2) were enriched for both Prolac-
tin and Estrogen Receptor signaling, in addition to other 
pathways associated with hormonal responses and tissue 
homeostasis. Cells from cluster hEC4, classified as luminal 
progenitor PRLR cells were marked by the enrichment of 
NRF2 and RANKL/RANK signaling pathways, which have 
been described to regulate the homeostasis and differentia-
tion of luminal progenitor cells [108, 109]. Predicted epi-
thelial bipotent breast cells (hEC3) were enriched for breast 
stem-associated signatures, such as PDGF pathway, which 
is known to control the proliferation of mesenchymal cells 
in the breast [110], and Signal transduction through IL1R 
[111], suggesting a stem-like phenotype of these cells. Cells 
classified as myoepithelial progenitors (hEC5) and myoepi-
thelial differentiated breast cells (hEC6) shared pathways 
associated with Cell contractibility, a hallmark of such cel-
lular fate. Moreover, cells from cluster hEC5 were enriched 
for genes associated with Androgen receptor signaling, and 
inhibition of this pathway has been shown to enhance the 
estrogen-induced, proliferation of breast epithelial cells 
[112].
We next investigated whether our expanded signature 
of human breast lineages would define the identity of epi-
thelial cells from additional scRNA-seq studies. In doing 
so, we validated our approach on a dataset that integrated 
scRNA-seq of FACS-isolated, human breast epithelial cells 
and tissue spatial analysis to define heterogeneity among 
mammary populations (NgNC, sample Ind #4) [20]. With 
the utilization of prediction models, we found a substantial 
overlap across cellular distributions between both datasets. 
This result was obtained despite the reduced number of 
human breast epithelial cells present in our dataset, sup-
porting that our methodology is compatible with low-input 
samples and is sufficient for delineating the overall epithelial 
diversity present in the human breast sample (Supplemen-
tary Fig. S12A). Interestingly, cluster hEC4, defined in our 
dataset to represent a small population of luminal progenitor 
cells was predicted to be absent in the Ind#4 dataset, 
Fig. 5  Expanding the molecular signature of epithelial and non-
epithelial human breast tissue. (A) UMAP plot showing cluster 
distribution of non-cancerous, total breast tissue sample, from nul-
liparous women (n = 5, hTM). (B) Feature UMAP plots showing 
expression levels of EPCAM, SERPINE1, CD3E, MS4A1, CLDN5 
and MYLK mRNAs in hTM clusters. (C) Dot plot and dendrogram 
branching showing the average and percentage of expressed genes 
that distinguished and classified clusters of epithelial cell lineages 
(hECs). (D) Diffusion map projection showing a Monocle-informed 
transcriptional trajectory arrangement of hEC clusters. The arrows 
serve to suggest that cells likely part of a bipotential progenitor fate 
(hEC3) give rise to myoepithelial progenitors (hEC5) and predicted 
luminal progenitors (hEC2 and hEC4). (E) Dot plot and clustering 
(dendrogram) of hNEC clusters shows the average and percentage of 
expressed genes that support classifying clusters, which include non-
immune populations of breast resident cells like endothelial cells, 
fibroblasts and adipocytes
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suggesting a potential challenge in the identification of rare 
cell populations. However, given that the parity state of this 
sample was unknown, the absence of this population could 
also reflect intrinsic changes to breast tissue due to devel-
opmental variation (Supplementary Fig. S12B). Analyses 
of additional datasets derived from FACS-isolated, breast 
epithelial tissue from nulliparous women (NgNC, sample 
Ind #5, Ind #6 and Ind #7) [20] also demonstrated substan-
tial overlap across cellular distributions with our datasets, 
thus supporting the overall representation of major breast 
cell lineages across independently generated scRNA-seq 
profiles (Supplementary Fig. S12C). Within this set of 
analyses, cluster hEC2 defined in our dataset to represent 
a population of luminal differentiated ESR1 cells were not 
detected across additional nulliparous samples (Supplemen-
tary Fig. S12D). These findings may suggest that in addi-
tion to parity state, tissue diversity across individuals, tissue 
dissociation approaches, or focused epithelial cell isolation 
could also influence the diversity of breast epithelial cells 
identified in scRNA-seq analysis.
Together, these results support that the expansion of gene 
signatures, that define lineage identities of breast resident 
cells, is required for understanding cellular dynamics and 
heterogeneity during tissue homeostasis. More importantly, 
taking the approach of defining baseline, cellular identities 
may also improve our understanding of developmentally-
induced alterations, including those that support cancer 
development and progression.
Next, we defined the non-epithelial population of breast 
resident cells. For this analysis, hTM clusters with low or 
absent expression of epithelial markers (EPCAM, KRT8, 
KRT18 KRT5, and KRT14) were re-clustered, yielding nine 
clusters of human non-epithelial cells (hNEC), which were 
further classified based on markers that defined mouse mam-
mary lineages (Fig. 4), and the top DEGs for each cluster 
(Supplementary Fig. S13A, B and Supplementary File S9).
This analysis identified three clusters with myeloid-like 
lineage identities (hNEC1, hNEC3, and hNEC4), which 
were further classified as neutrophil-like cells (hNEC1), 
macrophage-like cells (hNEC3) and monocyte-like 
cells (hNEC4), according to their expression of Colony 
Stimulating Factor 1 (CSF1), Msh Homeobox 1 (MSX1), 
Aldo–keto reductase family 1 member C (AKR1C1) 
(macrophage markers) [113], CXCL1, FERM Domain 
Containing 4A (FRM4A), C-X-C Motif Chemokine 
Ligand 6 (CXCL6) (neutrophil markers) [114, 115], and 
Carboxymethylenebutenolidase homolog (CMBL), Proline 
Rich and Gla Domain 3 (PRRG3) and Hemicentin 1 (HMCN1) 
(monocyte markers) [116]. We classified an additional 
population of myeloid cells as dendritic cells (hNEC6), given 
the expression of classical markers such as Basic Leucine 
Zipper ATF-Like Transcription Factor 3 (BATF3), Membrane- 
spanning 4-domains subfamily A member 6A (MS4A6A), 
and TYROBP (Fig.  5E and Supplementary Fig. S13C). 
Interestingly, one cluster uniquely expressed the T-lymphocyte 
marker CD3E (hNEC2) and other T-cell-like markers, 
such as CD8 alpha chain (CD8A), Granzyme K (GZMK), 
Granzyme M (GZMM) and GZMA as well as markers that 
define NKT-like phenotype such as NKG7, Killer cell lectin- 
like receptor subfamily B member 1 (KLRB1) and Cluster of 
Differentiation 96 (CD96). These observations taken together 
support a CD8 + NKT-like lineage identity for hNEC2. We 
also identified one cluster of cells expressing MS4A1 and 
BLNK mRNAs, defined as a cluster of B-cells (hNEC8).
Our analysis also identified non-immune, non-epithelial 
populations of human breast resident cells, namely Endothe-
lial cells (hNEC7), Fibroblasts (hNEC9) and Adipocytes 
(hNEC5), which were characterized by markers such as 
CLDN5, Serum deprivation-response protein (SDPR), 
and SRY-related HMG-box (SOX18) (endothelial cells) 
CLD, MYLK, Phospholamban (PLN) and Integrin alpha-7 
(ITGA7) (fibroblasts) [22, 103, 117–119], and Phospholi-
pase A2 Group VII (PLA2G7), Leptin Receptor (LEPR), and 
WNT1-inducible-signaling pathway protein 2 (WISP2) (adi-
pocytes) [120, 121] (Fig. 5E and Supplementary Fig. S13C). 
These results illustrate the diversity of immune and stromal 
cells in the normal breast and provides gene signatures that 
differentiate cells from other lineages, a resource that may 
enable the identification of cell types and their relevance in 
normal breast biology.
Collectively, our whole-tissue sequencing approach and 
re-clustering strategies have improved our understanding 
of cellular lineages that reside non-cancerous, nulliparous, 
human breast tissue.
The Evolutionary Conserved Basis of Murine 
and Human Breast Epithelial Identity
Our scRNA-seq re-clustering strategy and gene signatures 
allowed for the identification of diversity across resident 
cells from the murine and human breast. More specifically, 
our analysis indicated similar mammary epithelial cellular 
hierarchy and lineage commitment across species, support-
ing a body of research that has long utilized mouse mod-
els to understand basic process of normal and malignant 
development. Therefore, we next utilized scRNA-seq pro-
files from murine and nulliparous human breast epithelial 
tissue to define the relationships across distinct cell popu-
lations and identities across species. Clustering analysis 
resolved fifteen clusters, represented with cells obtained 
from murine scRNA-seq datasets (cells yielded from Pro- 
tocol #1 and Protocol #2) and  datasets generated 
from human breast tissue obtained from healthy, nullipa-
rous, women (five hTM datasets, NgNC Ind #5, NgNC 
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Ind #6, and NgNC Ind #7 datasets, [20] (Supplementary 
Fig. S14A, B, C, and D and Supplementary File 10).
Clustering of merged human and murine cells express-
ing the epithelial markers EPCAM, KRT8, KRT18, KRT5 
and KRT14 (mhTC2, mhTC4, mhTC5, mhTC6, mhTC7, 
mhTC8, mhTC10, mhTC11, mhTC12), yielded ten 
clusters of epithelial cells (Fig. 6A and Supplementary 
Fig. S15A, B). Cell abundancy analysis indicated that all 
datasets were to some extent represented across all ten 
mhEC clusters (Fig. 6B and Supplementary Fig. S15C). 
Clusters mhEC1, mhEC2, mhEC3, mhEC5, mhEC6 and 
mhEC10 bared higher human-MEC cell abundance, and 
gene signatures that support their classification as myoepi-
thelial lineages (mhEC2 and mhEC5), and luminal ductal-
like RCAN + MECs (mhEC1, mhEC6 and mhEC10) 
(Fig. 6C, D). Cluster mhEC3 was identified as luminal 
ductal-like RCAN + KRT14 + MECs, a population that 
may represent a previously described subset of lobular 
luminal cells [122], alluding to the usefulness of scRNA-
seq analysis into defining breast epithelial cells with spe-
cific spatial distribution breast tissue. Moreover, we also 
identified cluster mhEC8 as being biased towards a murine 
MEC-fate, a population of luminal-like cells with higher 
expression of LALBA mRNA (Fig. 6B, C, Supplementary 
Fig. S3A and Supplementary Fig. S4D).
Clusters evenly composed of murine and human cells 
spanned several MEC progenitor-like, lineage identities 
(Fig. 6C, D). Molecular signatures classified cells under 
cluster mhEC4 as potential bipotent MECs, given the 
expression of genes that mark both myoepithelial and 
luminal lineage identities. A population of epithelial cells 
(cluster mhEC7) was marked by higher levels of TET2 
mRNA abundant levels and expression of previously 
described genes that support both ductal-like hormone 
sensing and alveolar-like secretory identities, suggesting 
a luminal common progenitor identity (Fig. 6C, D).
Collectively, our comparative analysis of breast epi-
thelial cells from mouse and human tissue supports the 
relevance of an expanded gene signature to define line-
age identity and represents an initial attempt into under-
standing the evolutionary conservation of breast epithelial 
heterogeneity across mice and humans, and their specific 
relevance during breast development.
Discussion
Differential tissue fractionation techniques, along with 
gene signatures published from studies that investigate tis-
sue cellular heterogeneity have independently proven to be 
valuable tools in defining minute differences between cell 
populations and lineages. In this study, we describe a strat-
egy that exploits the benefits of both these methodologies, 
thus avoiding cell-specific isolation, and allowing a deeper 
understanding of the differences and similarities that 
define lineage hierarchies and cellular heterogeneity in 
complex, dynamic tissues such as the mammary gland.
Using this approach, we expanded gene signatures that 
defined an array of epithelial and non-epithelial cell popula-
tions from murine and human mammary gland tissue. The 
characterization of such gene signatures identified the pres-
ence of small populations of mammary bipotential, com-
mon progenitor cells, possibly at the apex of the hierarchi-
cal tree, and populations of lineage-specific progenitors and 
subsequent, differentiated epithelial cells. Moreover, these 
signatures also allowed for the identification of cell popula-
tions in cases were previously defined lineage markers were 
expressed at low levels. For example, our expanded gene sig-
nature enabled the identification of bipotential-like MECs, 
independently of the low levels of Procr mRNA, a marker 
of stem-like mammary cells [8]. This example supports 
the rationale for an expanded gene expression signature, 
to broadly define cellular states, especially in cases where 
cell preparation, isolation, or even mouse strain could repre-
sent confounding technical variables that may influence the 
expression of genes and the classification of MECs.
It is important to note that re-clustering approaches based 
on cellular transcriptional output may exaggerate population 
differences without substantial phenotypic relevance. There-
fore, to exclude such biases in our analyses, we validated 
our analytical approach and gene expression signatures in 
multiple datasets that profiled murine and human mammary 
epithelial cells. Such comparative analysis confirmed that 
our analytical approach and molecular signatures enable the 
identification of MEC identities across all analyzed datasets.
Our analyses may also be useful during the develop-
ment of transgenic systems to define essential drivers of 
cell survival, signaling and cellular identity/lineage during 
mammary gland development. Our expanded expression 
signatures identified lineage-biased genes that can be used 
as drivers of lineage tracing strategies and single mol-
ecule mathematical predictions. These strategies, in con-
junction with single-cell transcriptomics, are instrumental 
in resolving long-standing questions regarding mammary 
epithelial cell hierarchy and stemness.
Further highlighting the importance of our strategy, 
we were able to identify a series of immune and stromal 
cell populations that reside in murine and human mam-
mary tissue, including rare cell populations, like NKT-
like cells and adipocytes. Such analyses allowed for the 
elaboration of gene signatures that may be utilized in addi-
tional scRNA-seq profiling studies to provide a glimpse 
of their functional characteristics across different stages 
of mammary gland development. In addition, our ability 
to profile and identify epithelial and non-epithelial cells 
in mammary tissue from never pregnant female mice 
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allowed for the analysis of gene signatures that predict 
parity state [123–126]. Our findings elucidated that such 
signatures were not restricted to epithelial cells alone, but 
also extended to non-epithelial cell populations, raising 
the hypothesis that pregnancy signals change the tran-
scriptional output, and perhaps function, of all mammary 
resident cells.
Our study of mammary epithelial and non-epithelial cells 
was also extended to understand the cellular heterogeneity 
of human breast tissue. We found substantial concurrence 
in the gene signatures we defined, for epithelial and non-
epithelial cell lineages, across both species, supporting the 
functional conservation of molecular processes across mam-
malian evolution. Further experimental validation of these 
defined signatures, using organoid cultures or humanized 
mammary transplant models, will be invaluable in advanc-
ing our understanding of the functional relevance of cellu-
lar lineage hierarchies and transitional dynamics, in mouse 
and human breast tissue. Most importantly, exploitation of 
these strategies will enable the understanding of cellular 
dynamics and transcriptional alterations brought to MECs by 
pregnancy hormones, thus providing comparative, lineage-
defining approaches to understand mammary development 
across mammalian species.
Finally, the utilization of comprehensive gene signatures, 
comparative analysis not only allow for epithelial cell type 
identification that is conserved in murine and human breast 
tissue, but also revealed cell populations that are exclusive 
to each mammalian system. Interestingly, our results pointed 
to a more even distribution of stem-like and early progenitor 
MECs across mouse and human mammary tissue, suggesting 
the retention of hierarchical points of epithelial cell origin 
across species, while its evolutionary diversity is represented 
by more specialized cell types. A deeper dive into how tissue 
homeostasis, lineage commitment and cellular differentia-
tion is controlled across evolutionary distant mammalian 
species will improve the interpretation and definition of 
models that better depict mammary gland function in more 
evolved species.
By defining strategies that identify commonalities 
across mouse and breast tissue, our study provides tools 
and reference signatures that define diversity across differ-
entiation timelines, to enable deeper investigation into the 
transitional dynamics of normal and malignant mammary 
gland development.
Methods
Murine Mammary Tissue Processing Balb/c female mice 
(12 – 20 weeks old) were utilized for the generation of scR-
NAseq profiles. In short, mammary glands (four to five pairs 
per mouse) were harvested from never pregnant female mice 
and processed for the selective enrichment of Epithelial cells 
(Protocol #1 (two mice) = three minutes of mechanic minc-
ing, with 2.5 h enzymatic digestion) or for enrichment of 
Non-Epithelial cells (Protocol #2 (two mice) = one minute of 
mechanic mincing, with one-hour enzymatic digestion) with 
1 × Collagenase/Hyaluronidase (10 × solution, Stem Cell 
Technology) at 37o.C (constant agitation) in RPMI 1640 
GlutaMAX supplemented with 5% FBS. Digested mammary 
tissue was washed with cold HBSS supplemented with 5% 
FBS, followed by incubation with TrypLE Express (Thermo 
Fisher, #12,604–013) and an additional HBSS wash. Cells 
were then incubated with Dispase (Stem Cell Technology) 
supplemented with 40U DNAse I (Sigma, #D4263) for two 
minutes and filtered through a 100∝m Cell Strainer (BD 
Falcon, #352,360). All animals were housed at a 12 light/12 
dark cycle, with a controlled temperature of 72 °F and 40- 
60% of humidity. All experiments were performed in agree-
ment with approved CSHL Institutional Animal Care and 
Use Committee (IACUC).
Antibodies The following antibodies were used for the flow 
cytometric validation of DEG markers. All antibodies were used 
without further purification. Antibodies for lineage depletion: 
biotinylated anti-CD45 (eBioscience, #13–0451-85, 1:100 
dilution), biotinylated anti-CD31 (eBioscience, #13–0311-85, 
1:100 dilution), and biotinylated anti-Ter119 (eBioscience, 
#13–5921- 85, 1:100 dilution). Antibodies for flow cytometry: 
eFluor450-conjugated anti-CD24 (eBioscience, #48–0242-82, 
1:100 dilution), PE-Cy7-conjugated anti-CD29 (eBioscience, 
#25–0291-82, 1:100 dilution), Alexa Fluor® 647-conjugated 
anti-Cytokeratin 5 [EP1601Y](Abcam, #ab193895, 1:200 
dilution), Alexa Fluor® 594-conjugated anti-Cytokeratin 8 
(Santa Cruz Biotechnology, #sc-8020 AF594, 1:20 dilution), 
APC-conjugated anti-CD133 (BioLegend, #141,208, Dilution 
1:40), BV711- conjugated anti-CD61 (BD Biosciences, 
#740,677, Dilution 1:40), FITC-conjugated anti-CD52 
(Santa Cruz Biotechnology, #sc-51560 FITC, Dilution 1:40), 
PE-conjugated anti-CD79a (Abcam, #ab177274, Dilution 
1:40), PE-conjugated anti-p63 (Santa Cruz Biotechnology, 
#sc-25268 PE, Dilution 1:20), Alexa Fluor® 700-conjugated 
Fig. 6  The evolutionary conserved basis of murine and human 
breast epithelial identity. (A) UMAP plot showing the distribution 
of epithelial cells identified to be present in murine and human breast 
tissue datasets (mhEC). (B) Cell abundance distribution of murine 
(Protocol #1 and Protocol #2, mEC) and human (hEC, NgNC Ind 
#5, NgNC Ind #6, NgNC Ind #7) breast tissue datasets. (C) Dot plot 
and dendrogram branching showing the average and percentage of 
expressed genes that distinguished and classified clusters of epithelial 
cell lineages present in murine and human breast tissue datasets. (D) 
UMAP plot illustrating the lineage identity of epithelial cell lineages 
present in murine and human breast tissue datasets
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anti-Lgr5 (R&D Systems, #FAB82401N, Dilution 1:40), Alexa 
Fluor® 488-conjugated anti-CA II (Santa Cruz Biotechnology, 
#sc-48351 AF488, Dilution 1:20), APC-conjugated anti- 
Lalba (LS Bio, #LS-C716395-200, Dilution 1:40), and PE- 
conjugated anti-Tet2 (Cell Signaling Technology, #79,468, 
Dilution 1:50). OneComp eBeads™ Compensation beads 
(Invitrogen, #01–1111-42) were used for negative and positive 
compensation controls.
Flow Cytometry  Mammary glands (four per mouse) were 
harvested, minced and incubated for ~ 2.5 h with 10 × Col-
lagenase/Hyaluronidase in DMEM (Stem Cell Technology, 
#07,912, Dilution 1:10) in RPMI1640 GlutaMAX™ supple-
mented with 5% FBS. Digested mammary gland fragments 
were washed with cold HBSS supplemented with 5% FBS, 
followed by incubation with pre-warmed (37 ºC), TrypLE 
Express (Thermo Fisher, #12,604–013) for five minutes at 
room temperature and an additional HBSS wash. Cells were 
incubated with 1 mL of Dispase in HBSS (Stem Cell Tech-
nology, #07,913, 5 U/ml) supplemented with 40 µL DNAse I 
(Sigma, #D4263) for two minutes and then filtered through a 
100µm Cell Strainer (BD Falcon, #352,360). The single cell 
suspension was incubated with lineage depletion antibodies 
and Anti-Biotin MicroBeads (Miltenyi Biotec, #130–090-
485), followed by loading onto MACS LS column (Milte-
nyi Biotec, #130–042-401). Flow- through cells (lineage 
negative, epithelial cells) were collected and stained with 
antibodies against surface antigens for 40 min at 4 ºC. The 
stained cells were washed in 1X MACs buffer and fixed in 
1% PFA for 20 min at room temperature. Cells were then 
permeabilized using Invitrogen eBioscience™ Foxp3/Tran-
scription Factor Staining Buffers (Invitrogen #00–5523-00) 
and stained with antibodies against intracellular antigens 
diluted in Invitrogen 1 × Perm/wash buffer for 40 min at 
room temperature. Surface and intracellular stained cells 
were re-suspended in 1X MACs buffer and filtered prior to 
acquisition. Flow cytometry acquisition was carried out on 
the Dual Fortessa II cell analyzer (BD Bioscience). Data 
analysis was performed using FACSDiva™ 8 software (BD) 
and FlowJo™ Software (BD).
Human Mammary Tissue Processing Non-identified, non- 
cancerous, human breast tissue (n = 5) was obtained from 
healthy, nulliparous women undergoing cosmetic breast 
reduction surgery via the Northwell Health Tissue Dona-
tion Program (TDP). Surgically removed tissue was minced 
for five minutes and digested with 1 × Collagenase/Hyalu-
ronidase (10 × solution, Stem Cell Technology) at 37o.C 
(constant agitation) in RPMI 1640 GlutaMAX supple-
mented with 5% FBS, for 4–6 h. Digested mammary tissue 
was washed with cold HBSS supplemented with 5% FBS, 
followed by incubation with TrypLE Express (Thermo 
Fisher, #12,604–013) and an additional HBSS wash. Cells 
were then incubated with Dispase (Stem Cell Technology) 
supplemented with 80U DNAse I (Sigma, #D4263) for two 
minutes and filtered through a 100µm Cell Strainer (BD Fal-
con, #352,360). Tissue collection and handling performed in 
agreement with approved CSHL Institutional Review Board 
(IRB).
scRNA‑Seq Library Preparation For the mouse mammary 
tissue analysis, five thousand total mammary cells with a 
viability of > 90% were used for cDNA synthesis and library 
preparation utilizing the 10 × Chromium platform. Single-
cell libraries were run using single-end sequencing with 
indexing on a NextSeq 550 high output platform. Human 
mammary tissue scRNAseq library preparation and sequenc-
ing were performed by the New York Genome Center, utiliz-
ing in-house developed protocols and sequencers.
scRNA‑seq Data Analysis Murine (two samples, each 
sample prepared from mammary glands pulled from two 
mice) and human (five samples) scRNA-seq data were 
aligned to mm10 and hg19 genomes respectively, using 
CellRanger version 3 [127] and downstream data processing 
was performed using Seurat version 3.2.0 [128]. Murine 
scRNA-seq samples were merged into a single Seurat 
object (Sobj) as were human scRNA-seq samples. For batch 
normalization, anchors were found between the merged 
datasets using the FindIntegrationAnchors() function and 
then integrated using the IntegrateData() function [129]. 
For the murine Sobj, 15,359 total murine cells (mTM) 
were utilized, with quality control steps were taken at each 
at each re-clustering phase, resulting in the removal of 
clusters deemed to be low quality based on an average of 
cells expressing comparatively low or high features or a high 
percentage of mitochondrial content. For the human Sobj, 
cells with fewer than 500 or more than 10,220 features were 
removed, as were cells with greater than 15% mitochondrial 
content, resulting in 2,053 total human cells (hTM). 
Similarly, quality control was employed and checked at each 
re-clustering approach to remove comparatively low-quality 
clusters. Doublets were identified and removed in both 
Sobjs. Processing for both datasets started with a principal 
component analysis (PCA) using the top 2,000 variable 
genes to identify the number of significant components 
before clustering. Uniform manifold approximation and 
projection (UMAP) clustering was performed by calculating 
a shared nearest neighbor graph (SNN), using a resolution 
of 0.5. Epithelial cells for both datasets were defined by the 
expression of Epcam, Krt8, Krt18, Krt5 and Krt14(cluster 
average expression > 2). Non-epithelial were cells 
considered having low expression of Epcam, Krt8, Krt18, 
Krt5 and Krt14. Epithelial and non-epithelial clusters were 
separated using the subset() function and then formed to 
new Sobjs after re-clustering. For the murine epithelial and 
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non-epithelial Sobj as well as both human Sobj, re-clustering 
was performed by calculating a SNN using ten dimensions 
and a resolution of 0.5. Low quality clusters were identified 
and removed resulting in 2,016 epithelial cells (EC) and 
12,646 non-epithelial cells (NEC) in murine Sobjs, and 440 
epithelial cells (hEC) and 1,456 non-epithelial cells (hNEC) 
in human Sobjs. The FindMarkers() function, which uses a 
Wilcoxon rank-sum test to identify differentially expressed 
genes, was implemented to determine differentially 
expressed genes between clusters. Visualization functions 
such as DotPlot(), FeaturePlot(), VlnPlot(), and HeatMap() 
were utilized to examine differentially expressed genes and 
markers of interest. The BuildClusterTree() function was 
employed with default parameters to generate dendrograms 
of clusters. Construction of cellular trajectories within 
epithelial clusters was conducted using Monocle 3 [130]. 
The SingleR package was used for annotation of our human 
Sobj against publicly available datasets which included 
DICE, HPCA, Monaco and NoverHem, all of which were 
attained through Bioconductor [93, 131–134].  Retrieval 
of Bach et  al. dataset was achieved through the use of 
BachMammaryData(), which was then processed into 
separate Sobjs based on mammary gland developmen-
tal timepoints. Following the same procedure previously 
described, data was clustered and visualized in UMAP 
plots. Cell identities in the Bach et al. datasets were pre-
dicted through use of our generated cell identities in our 
murine epithelial dataset as a reference when implementing 
the FindTransferAnchors() function. These anchors were 
then inputted into the TransferData() function to determine 
a predicted murine epithelial cluster identification 
for each cell in the Bach et al. dataset [8, 135]. For cross-
species joint scRNA-seq analysis, mouse and human one-
to-one orthologs were retrieved from [136]. Mouse gene 
names were first converted to its orthologous human gene 
names, then human and mouse samples were merged 
using Seurat. Cells with fewer than 200 or more than 6000 
features were removed for quality control. The final 
integration of human and mouse samples resulted in 15,200 
murine cells and 23,608 human cells as well as 14,928 genes 
for further analysis. Other parameters used in the processing 
steps are kept the same as those in murine analysis, including 
both PCA and UMAP for generating clusters for all cells and 
re-clustering for epithelial cells. After sub-setting epithelial 
cells (i.e., cells with high expressions of Epcam, Krt8, 
Krt18 and Krt5), Monocle 3 was used to construct cellular 
trajectories within the epithelial clusters. Pathway analysis 
was performed using Enrichr [137, 138].
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